#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Endometrial cancer recurrent Sickle cell anaemia Pouchitis Hypergammaglobulinaemia benign monoclonal Breast angiosarcoma Muscular dystrophy Niemann-Pick disease Alveolar proteinosis Pulmonary alveolar haemorrhage Hypereosinophilic syndrome Lung adenocarcinoma Mantle cell lymphoma stage IV Pseudoxanthoma elasticum Thyroid cancer metastatic Fibrosarcoma More trials…

    Learn about Rare Diseases

    CADASIL – Life with Disease Mantle cell lymphoma refractory – Diagnostics Stevens-Johnson syndrome Hereditary motor and sensory neuropathy – Basic Information Rhabdomyosarcoma – Trials in Disease Mantle cell lymphoma stage IV – Treatment Ewing’s sarcoma – Life with Disease Krabbe’s disease Antisynthetase syndrome – Treatment Krabbe’s disease – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Adapalene Ttf-Ngr Cx-044933 Astegolimab Paracetamol Ph. Eur. Giroctocogene Fitelparvovec Bendamustine Cefoxitin Sodium ACT-1004-1239 Oleclumab Odevixibat Lavender Oil OMECAMTIV MECARBIL Tulisokibart Nafarelin Desonide Iodixanol Enfortumab Vedotin Cefazolin Sodium Raxtozinameran More therapies…

    Learn about Your Condition

    Red blood cell abnormality Osteomyelitis acute Krabbe's disease Essential thrombocythaemia Apheresis Haemodynamic instability Testicular leiomyosarcoma Giant cell arteritis Oesophageal adenocarcinoma Hypogonadism male Hypochromic anaemia Fibrosarcoma Lung adenocarcinoma Myofascial pain syndrome Graft infection More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Short-bowel syndrome

  • Study of glepaglutide compared to placebo for patients with short bowel syndrome with intestinal failure

    Recruiting

    3 1
    Investigated Diseases:
    • Short-bowel syndrome
    Investigated Drugs:
    • Glepaglutide
    Austria Belgium Czechia Denmark Estonia Finland +9

  • Study on How Apixaban and Teduglutide Affect Patients with Short Bowel Syndrome on Long-Term Parenteral Nutrition

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Short-bowel syndrome
    Investigated Drugs:
    • TEDUGLUTIDE
    • Apixaban
    Belgium

  • Study on the Effects of Rivaroxaban in Patients with Short Bowel Syndrome on Long-Term Parenteral Nutrition

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Short-bowel syndrome
    Investigated Drugs:
    • Rivaroxaban
    The Netherlands

  • Study of HM15912 for Adults with Short Bowel Syndrome-associated Intestinal Failure

    Recruiting

    2 1
    Investigated Drugs:
    • Human Glucagon-Like Peptide-2 Analogue Linked To A Human Immunoglobulin Fc Fragment
    Belgium Denmark France Germany Poland

  • Study on Crofelemer for Adults with Short Bowel Syndrome and Intestinal Failure Without Colon in Continuity

    Recruiting

    2 1
    Investigated Diseases:
    • Short-bowel syndrome
    Investigated Drugs:
    • Crofelemer
    Germany Italy

  • A Study to Evaluate the Long-Term Safety of Glepaglutide in Adult Patients with Short Bowel Syndrome Who Participated in Previous Studies

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Short-bowel syndrome
    Investigated Drugs:
    • Glepaglutide
    Belgium France Germany Poland
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!